Show simple item record

dc.contributor.authorLuggya, Tony Stone
dc.date.accessioned2014-05-06T15:15:21Z
dc.date.available2014-05-06T15:15:21Z
dc.date.issued2011
dc.identifier.citationLuggya, T. S. (2011). The effect of ketamine on production of inflammatory markers in post operative patients in Mulago Hospital: A randomized clinical trial. Unpublished masters thesis, Makerere University, Uganda.en_US
dc.identifier.urihttp://hdl.handle.net/10570/2636
dc.descriptionA research dissertation submitted in partial fulfillment of the requirements for the award of the Degree of Master of Medicine ( Anaesthesiology) of Makerere University.en_US
dc.description.abstractBACKGROUND: Mulago hospital provides anaesthesia services for many patients undergoing surgical procedures. Anaesthesia and surgery are associated with immune system response, manifested as an increased pro-inflammatory immune mediator release or increased pain modulation, which may affect or prolong postoperative recovery. Ketamine, a cheap and readily available anaesthetic induction agent, has been reported to have attenuation effects in atopic individuals and asthmatics, and improves paediatric patient outcomes after cardiac surgery. RESEARCH QUESTION: Can 0.5mg/kg of Ketamine given preoperatively have an effect on the post operative levels of pro-inflammatory markers? STUDY OBJECTIVE: To study the effect of, low dose, 0.5mg/kg of Ketamine administered preoperatively on the postoperative pro-inflammatory marker IL-6 and IL-1beta levels, in adult patients undergoing elective surgery in Mulago hospital. STUDY METHOD: A stage 2 phase 4, prospective, randomized, double-blind, placebocontrolled trial was conducted in the main operating theatres of Mulago hospital among patients undergoing elective surgery. 39 patients were recruited and randomized to receive either IV ketamine 0.5 mg/kg or an equal volume of normal saline before induction of anesthesia. Blood samples were taken at baseline before administering intervention, in PACU, 24 and 48 hours post operatively. These determined the IL-1β and IL-6 levels. The study was registered under the clinical trials domain www.clinicaltrials.gov ClinicalTrials.gov Identifier: NCT01339065 RESULTS: Indicated 0.5 mg/kg ketamine given at induction added to Opioid-based anesthesia, suppresses the increase of serum IL-6 at PACU and at 24 hours after surgery. IL-beta was not found in 98% of analyzed samples of the surgical population studied as there was no reaction in the pre-coated ELIZA antibodies micro wells on assay. CONCLUSION: Serum IL-6 levels correlate with patient’s clinical course during and after surgery it is therefore recommended, that in non contraindicated patients, low dose ketamine is beneficial.en_US
dc.description.sponsorshipAAGBI and GPASen_US
dc.language.isoenen_US
dc.publisherMakerere Universityen_US
dc.subjectKetamineen_US
dc.subjectInflammatoryen_US
dc.subjectMulago Hospitalen_US
dc.subjectPost operative patientsen_US
dc.titleThe effect of Kitamine on production of inflammatory markers in post operative patients in Mulago Hospital: A randomized clinical trial.en_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record